Leqvio (inclisiran)

pCPA File Number: 22830
Negotiation Status:
Active Negotiation
Indication(s):
Primary hypercholesterolemia
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0791-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable